The serendipitous story of SGLT2i in the treatment of heart failure Published 2022-03-17 Download video MP4 360p Download video MP4 720p Recommendations 1:00:18 Surgical repair of the mitral valve 1:03:25 What’s New in 2023 in the Management of Heart Failure? 42:24 Cardiogenic Syncope - For the Faint of Heart | The Heart Course 06:04 Canadian Perspectives on ESC 2022 - DELIVER Trial 31:32 The surprising truth about histamine intolerance | Dr. Will Bulsiewicz 16:24 How SGLT2 Inhibitors Protect The Kidney 1:03:41 Evolution of SGLT2 Inhibitors from management of glycemic control , Dr. Sanjay Kaul, MD 09:06 SGLT2 Inhibitors in Chronic Kidney Disease 1:09:03 Heart Failure With an Improved Left Ventricular Ejection Fraction | Douglas Mann, MD 18:12 Heart failure - Enter the Emperor 1:07:16 Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination 07:51 Compensation and decompensation in heart failure | NCLEX-RN | Khan Academy 16:43 Lung Cancer Staging with the IASLC Lymph Node Map 12:49 ESC TV Conversations - SGLT2 inhibitors – wonder drugs in Heart Failure and beyond? 09:22 Dr. Scott Solomon: Dapagliflozin Benefits Patients With Heart Failure and Kidney Disease 1:00:25 How do mitochondria contribute to health and disease? - Peter McGuire 38:55 Professor Milton Packer - 'Heart failure – are there limits to anti-diabetic therapy with SGLT2' 09:06 Heart failure with reduced and preserved ejection fraction, pathophysiology and treatment 17:00 SGLT2i for HFpEF - Jacob Udell 13:49 Using SGLT2-inhibitors to treat cardiac patients with diabetes Similar videos 1:05:21 SGLT2 inhibitors in heart failure: New analyses and recent updates 13:07 Nurse Webinars - SGLT2i - Dapagliflozin and Empagliflozin 55:53 Finding the Sweet Spot: Prescribing SGLT2 Inhibitors in Heart Failure | Paige Skelton, PharmD, BCCP 1:23:07 SGLT2 Inhibitors & Cardiovascular Outcome 1:21:48 Cardiology Perspectives on Using SGLT2is to Optimize Outcomes in Patients With Heart Failure 02:40 The Cellular Actions of SGLT2i's 53:09 SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer" 23:00 Professor Niko Marx - The therapeutic importance of SGLT2 inhibition – heart failure the new target! 06:11 Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists 50:30 Protocols for Safe Use of SGLT2i and GLP1RA in the Hospital Setting 14:53 Fundamentals of SGLT2i's and GLP-1RA's for CV Risk 18:41 Dr. Chantal Mathieu - SGLT2i : Implications from Clinical Trials and Guidelines 1:07:35 SGLT2 inhibitors in cardiovascular disease 1:02:19 Cardiovascular, Renal and Metabolic Benefits of SGLT2i for Type 2 Diabetes and Heart Failure 59:24 CWMGR: The Expanding Multiverse of SGLTi In & Beyond Diabetes 41:48 PG Debate on SGLT2 inhibitors Dr Prithvi and Dr Amit 31:02 Bout 15 DIABETES AND HEART FAILURE – Choice of SGLT-2 INHIBITORS More results